Zurück
HuagongsheHuagongshe Chemie-Druckbericht · Nur für Forschungszwecke
HRID 82420Erstellt: 24. Oktober 2026

Formamide → tert-butyl 4-(5-vinyl-6,7-dihydro-5H-cyclopenta[d]pyrimidin-4-yl)piperazine-1-carboxylate

https://huagongshe.com/de/reaction/82420

Reaktionsgleichung

Beteiligte Stoffe

RolleNameHCIDEinwaage
EduktFormamideHCID 713—
EduktPotassium HydroxideHCID 14797—
EduktPhosphorus oxychlorideHCID 24813—
Edukttert-Butyl piperazine-1-carboxylateHCID 143452—
EduktAmmonium formateHCID 2723923—
EduktHCID 59682828HCID 59682828—
Edukt5-vinyl-6,7-dihydro-3H-cyclopenta[d]pyrimidin-4(5H)-oneHCID 136024470—
LösungsmittelWaterHCID 962—
LösungsmittelAcetonitrileHCID 6342—
LösungsmittelIsopropanol methylene chlorideHCID 21966342—
Produkttert-butyl 4-(5-vinyl-6,7-dihydro-5H-cyclopenta[d]pyrimidin-4-yl)piperazine-1-carboxylateHCID 5968282220%

Reaktionsbedingungen

Temperatur140 °C

Reaktionsschritte

Ethyl 2-amino-5-vinylcyclopent-1-enecarboxylate (2.132 g, 12.75 mmol) was mixed with ammonium formate (4.02 g, 63.75 mmol) and formamide (5.56 mL, 127.5 mmol) and heated at 140° C. for 16 hours. The mixture was diluted with water (50 mL) and 20% IPA-DCM (100 mL). Solids were filtered off (Celite). The organic layer was separated. The aqueous layer was extracted with 20% IPA-DCM (3×50 mL). The combined organic solutions were washed with brine (20 mL) and dried (Na2SO4). After filtration and concentration, toluene (10 mL) was added to the crude (1.543 g), mixed, and evaporated. The resulting 5-vinyl-6,7-dihydro-3H-cyclopenta[d]pyrimidin-4(5H)-one was mixed with acetonitrile (30 mL) and POCl3 (2.62 mL, 28.54 mmol) and heated at 80° C. for 20 hours. The mixture was cooled to 0° C. 50% KOH (11.25 mL, 142.7 mmol) was added dropwise. t-Butyl piperazine-1-carboxylate (5.31 g, 28.53 mmol) was added. The mixture was heated at 80° C. for 24 hours. The contents were concentrated. Water was added. The mixture was extracted with DCM (2×) and dried (Na2SO4). The crude material was purified with flash chromatography to give tert-butyl 4-(5-vinyl-6,7-dihydro-5H-cyclopenta[d]pyrimidin-4-yl)piperazine-1-carboxylate (855 mg, 20% for 2 steps). 1H NMR (CDCl3, 400 MHz) δ (ppm): 8.47 (s, 1H), 5.95-5.86 (m, 1H), 5.12-5.09 (m, 1H), 4.92-4.87 (m, 1H), 3.98-3.93 (m, 1H), 3.67-3.60 (m, 4H), 3.-3.39 (m, 4H), 2.94-2.76 (m, 2H), 2.35-2.27 (m, 1H), 1.90-1.82 (m, 1H), 1.47 (d, 1.47 (s, 9H). MS: 331.3 (M+1).

Herkunft & Nachweise

DOI10.6084/m9.figshare.5104873.v1
PatentnummerUS08846681B2
Quelldatensatzuspto-grants-2014_09
ORD IDord-50eca08b00e24e02a142dc563dedd3a1
Quellennotizuspto-grants-2014_09